BioCentury
ARTICLE | Company News

Intrinsic Bioprobes, J&J deal

January 25, 2010 8:00 AM UTC

Johnson & Johnson's Ortho-Clinical Diagnostics Inc. subsidiary received exclusive rights to two diabetes biomarkers from Intrinsic. The biomarkers are modified forms of blood-circulating proteins, whi...